Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)
- 6 December 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (1) , 55-58
- https://doi.org/10.1016/s0960-894x(00)00597-7
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Characterization of SB‐271046: A potent, selective and orally active 5‐HT6 receptor antagonistBritish Journal of Pharmacology, 2000
- In vivo effects of the 5‐HT6 antagonist SB‐271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5‐HT, glutamate and aspartateBritish Journal of Pharmacology, 2000
- 5-ht6 Receptors as Emerging Targets for Drug DiscoveryAnnual Review of Pharmacology and Toxicology, 2000
- Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strainsBehavioural Brain Research, 1999
- 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): A Potent, Selective, and Orally Bioavailable 5-HT6 Receptor AntagonistJournal of Medicinal Chemistry, 1999